ArticleMedicine2026
Trends in circulatory system disease hospitalizations in England and Wales: A 21-year secular-trend analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases (CVDs) are the primary reason for mortality worldwide. Patients with CVD were at higher risk of drug-related adverse events and functional impairment and were more likely to be admitted to the hospital. This study aims to study trends for CVD hospital admission (HA) in England and Wales during the past 21 years. A secular-trend analysis study design was utilized to explore the trend of CVD HAs. Poisson regression was used to examine the trend in HAs. To determine trends in admission rates over time, we implemented Joinpoint regression analysis. The permutation test was employed to determine the optimal number of Joinpoints, with the Bayesian information criterion being the basis for model selection, and robust standard errors were calculated to account for overdispersion. During the study period, CVD HAs increased 24.8%, although Joinpoint regression showed different patterns by disease category, age, and gender. Acute rheumatic fever declined in females (annual percent change [APC] = -7.3%) and children under 15 (APC = -4.49%) from 1999 to 2010, but increased after 2010. From 2005 to 2009, chronic rheumatic heart disease grew significantly in both sexes (APC ≈ 18%-20%) and gradually in those aged ≥75 (average annual percent change [AAPC] = 8.60%). Hypertensive diseases fluctuated, with spikes (1999-2010, APC = 8.90%), falls (2010-2013, APC ≈ -31% to -36%), and subsequent increases (APC ≈ 13%-14%). Significantly, pulmonary heart disease, circulation illnesses, and other heart and vascular diseases increased across all age groups (APCs = 5.32%-9.40%), particularly among those aged ≥75 (AAPC = 4.78%). Although ischemic heart disease declined with age (AAPC = -1.72% to -2.51%), cerebrovascular disease showed mixed trends, rising early and late but decreasing after 2009 in those ≥75 years. APCs exhibited short-term surges and dips within intervals, while AAPCs indicated long-term increases for pulmonary and hypertensive illnesses (mainly in younger adults) but declines for ischemic heart disease and cerebrovascular disease in older adults. In England and Wales, HAs owing to CVD have increased during the last 2 decades. Prevention programs for CVD are needed to improve public awareness about this common and serious group of diseases. The focus should be on reducing the prevalence of modifiable risk factors for these diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.